×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Will Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?
Yahoo Finance
While Acasti Pharma is showing a solid reduction in its cash burn, it's still worth considering how easily it could raise more cash, even just...
4 months ago
We're Keeping An Eye On Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
Simply Wall Street
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price.
1 week ago
Aker BioMarine acquires IP & equipment from Acasti Pharma Inc.
NutraIngredients-USA.com
Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related...
5 months ago
After laying off most staff, Acasti insists it's still on track
Fierce Biotech
Laying off most of your workforce is normally a sign of a biotech in a death spiral, but Acasti's CEO is insistent the move has energized...
10 months ago
Acasti Pharma Announces 1-for-6 Reverse Stock Split
PR Newswire
The reverse stock split will become effective July 10, 2023 at 12:01 a.m. ET. The Company's common shares will trade on a split-adjusted basis...
9 months ago
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
Projected Cash Runway Extends into Second Calendar Quarter 2026, Well Beyond Potential 1H 2025 Submission of GTX-104 New Drug Application...
2 months ago
Aker BioMarine acquires all krill-related patents from Acasti Pharma
Nutraceutical Business Review
Norway-based Aker BioMarine has acquired all krill-related patents, equipment, and scientific data from Acasti Pharma as a settlement...
6 months ago
Acasti: Fiscal Q3 Earnings Snapshot
Quartz
LAVAL, Quebec (AP) — LAVAL, Quebec (AP) — Acasti Pharma Inc. (ACST) on Monday reported a loss of $2.4 million in its fiscal third quarter.
2 months ago
Acasti Pharma Reports Fiscal Year 2023 Operational Results
PR Newswire
As a result of the strategic realignment plan announced on April 4, 2023 to prioritize resources to GTX-104, and away from GTX-101 and GTX-102,...
10 months ago
Kjell Inge Rokke's Aker BioMarine snaps up krill patents worth $3.1 million
IntraFish.com
Norway-based krill harvester and processor Aker BioMarine is acquiring all krill related patents, pre-clinical and clinical data and...
6 months ago